Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s share price dropped 0.8% during mid-day trading on Monday . The company traded as low as $1.20 and last traded at $1.20. 13,007 shares were traded during mid-day trading, an increase of 375% from the average session volume of 2,736 shares. The stock had previously closed at $1.21.
Ascletis Pharma Price Performance
The business’s 50-day moving average is $1.30 and its 200 day moving average is $1.63.
About Ascletis Pharma
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Featured Stories
- Five stocks we like better than Ascletis Pharma
- The Ultimate Cyber Shield: CrowdStrike Rises Past $235
- Palantir Just Told Wall Street Where AI Infrastructure Is Headed
- Homebuilders Are Down for the Year, Is Wall Street in Denial?
- Turning Trash to Cash: A $129M Bet on Waste
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
